ReleaseWire

GlobalData's clinical trial report, "Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for 2015 in Pharmaceuticals" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in 2015. The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Providing a natural and non habit forming solution for people to aid their sleep, Manzo Pharmaceuticals' SOMNAID is getting consistent five star reviews from customers. Manufactured in USA under strict GMP quality control guidelines, these pills have no side effects.

The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2016 report.

GlobalData's clinical trial report, "Thrombophilia Global Clinical Trials Review, H1, 2016" provides an overview of Thrombophilia clinical trials scenario. This report provides top line data relating to the clinical trials on Thrombophilia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Most micro- and small-cap biotechnology firms are development-stage opportunities with a lengthy commercialization timeline. For investors, these companies have relatively high risks due to the high costs and uncertainty of regulatory approval.

Healthcare-acquired infections (HAI) are a major threat to patients' safety. Organizations like the CDC and Public Health England monitor healthcare settings through routine surveillance programs to identify the infection type and make efforts toward prevention. According to the CDC, in 2015, one in 25 patients in the US suffered from HAI during hospital care. To prevent such HAI during a surgical procedure that involves general anesthesia, healthcare personnel advise the use of disposable anesthesia devices including laryngeal mask airways (LMA), face masks, breathing circuits, endotracheal tubes (ETT), and resuscitators. These masks will also prevent cross-contamination. Anesthesia disposables are single-use consumables.

Endocrinology deals with the study of the endocrine system, including the biochemical and physiological functions of the hormones, cells, and tissues of the endocrine glands. Endocrine disorders can be broadly subdivided into three categories: endocrine gland hyposecretion, which causes hormone deficiency, endocrine gland hypersecretion, which causes excess hormone secretion, and tumors in the endocrine gland. The endocrine disorders considered for the present report include diabetes, human growth hormone deficiency, thyroid disorders, and male hypogonadism.

Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.

An ampoule is a small vessel made of glass or plastic. It contains a medicinal solution, drug, or powder, which is used for injections. Ampoules are the most prevalent healthcare packaging solutions. Since packaging of medicines is a complex process because of their molecular and chemical structures, they need to be packed in protective and durable materials to prevent contamination. The evolution of new diseases and increased health awareness have brought a transformation in the ampoules packaging market. Companies are making use of high-tech glasses and green plastics to keep medicines safe and are prioritizing environmentally friendly products.

GlobalData's clinical trial report, "Delirium Global Clinical Trials Review, H1, 2016" provides an overview of Delirium clinical trials scenario. This report provides top line data relating to the clinical trials on Delirium. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Ascites Global Clinical Trials Review, H1, 2016" provides an overview of Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Cluster Headache Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Cluster Headache Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Cluster Headache Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Vaginal atrophy also known as atrophic vaginitis is defined as a decrease in the production of estrogen after menopause, leading to thinning, drying, and reduced elasticity of the vaginal tissues. Up to 40% of post-menopausal women have symptoms of atrophic vaginitis. It typically affects women in the age group of 45-55 years. PVA result in symptoms such as itching, burning, dryness, and dyspareunia. Topical preparations such as hormone replacement therapy (HRT) and estrogen creams are used to treat PVA.

CEO of Manzo Pharmaceuticals (OTCPink:MNZO) and creator of patented Lacto-Freedom probiotic, Kenneth Manzo, recently visited their manufacturer's GMP and FDA approved probiotic plant in the USA and expressed his great satisfaction with the manufacturer and their professionalism.

Golden Age Resources Inc. (OTCPINK:GDAR), a leading acquisition and development company, announced today that it entered the highly profitable pharmaceutical business with the signing of a term sheet with Biopharma Pravo alpha for the perpetual exclusive worldwide rights for six products for a potential of 20 billion dollar markets. Under the terms of the signed term sheet, GDAR will have an exclusive perpetual pre-paid worldwide rights for the following products focusing on cardiovascular, anti-microbial, immunity and pain relief.

ADCs, empowered monoclonal antibodies (mAbs), use chemical linkers with labile bonds to attach biologically active substances. ADCs target mAbs with the cancer killing ability of cytotoxic drugs, allowing sensitive discernment between healthy and diseased tissue.

GlobalData's clinical trial report, "Dysphagia Global Clinical Trials Review, H1, 2016" provides an overview of Dysphagia clinical trials scenario. This report provides top line data relating to the clinical trials on Dysphagia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Dystonia Global Clinical Trials Review, H1, 2016" provides an overview of Dystonia clinical trials scenario. This report provides top line data relating to the clinical trials on Dystonia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Diabetic Gastroparesis Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Cancer Pain Global Clinical Trials Review, H1, 2016" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

CEL-SCI Corporation("CEL SCI" or the "Company") today announced that during the month of April it has enrolled 41 patients in its ongoing Phase 3 trial of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) in patients with advanced primary head and neck cancer. This is a new monthly enrollment record, surpassing the prior record of 38 patients enrolled in October 2015. Total patient enrollment for the trial is now 797 as of April 30, 2016.

GlobalData's clinical trial report, "Duodenal Ulcer Global Clinical Trials Review, H1, 2016" provides an overview of Duodenal Ulcer clinical trials scenario. This report provides top line data relating to the clinical trials on Duodenal Ulcer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The Global Drug Delivery Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

This report provides all the information you require to better understand Salix Pharmaceuticals and its partnering interests and activities over the past five years.